logo
AHCS | Information Portal<p>The AHCS Information Portal is your one stop information area consisting of the Information Station & Health Hub.</p>AHCS | My CommunityAHCS | Support Forums
Treatment News
Title Filter     Display # 
# Article Title Author Hits
1 Hep C Inhibitor PSI-7977 Goes Interferon-Free in Phase III Studies Linda McInnes 191
2 Abbott Developing Potent Interferon-Free Hep C Regimen Linda McInnes 121
3 Russia develops effective drug to treat hepatitis C Linda McInnes 351
4 New Boehringer Ingelheim Hepatitis C Data to Be Presented at AASLD Linda McInnes 161
5 Anadys Positive 12-Wk Data for Setrobuvir in Phase 2b Hepatitis C Study Linda McInnes 252
6 WE NEED YOUR HELP – NEW HEP C TREATMENT Linda McInnes 377
7 Delays for New Hepatitis Treatment Linda McInnes 209
8 The Treatment Journey Linda McInnes 172
9 Part 1 & 2 – Boceprevir And Telaprevir Provide Higher Cure Rates Linda McInnes 466
10 MURDOCH University researchers have begun a study to develop a new and innovative vaccine for the hepatitis C virus (HCV). Linda McInnes 324
11 New Approach a Step Forward for Hepatitis C Vaccine Linda McInnes 320
12 Factors that Raise the Risk of Hepatitis C Relapse Linda McInnes 491
13 A Trio of New Hepatitis C Drugs Being Tested Linda McInnes 367
14 Nanogel Could Lead to Novel Hep C Vaccine Linda McInnes 251
15 Hepatitis C Drug TMC435 Gets Fast Tracked Linda McInnes 453
16 Quad Therapy Linda McInnes 394
17 Gene PNPLA3 offers potential therapeutic target in chronic hepatitis C liver damage Linda McInnes 500
18 Heavy Coffee Consumption Linked to Better Hep C Treatment Response Linda McInnes 469
19 Medivir Announces Positive 48-week Interim Data from TMC435 Hepatitis C Phase 2b ASPIRE Study in Treatment-Experienced Genotype-1 Patients Linda McInnes 195
20 FDA approves Incivek for hepatitis C Linda McInnes 340
21 May 23 Could Bring Approval for Vertex's Hep C Drug Linda McInnes 305
22 Boceprevir Wins FDA Approval to Treat Hepatitis C Linda McInnes 584
23 Top News from EASL 2011 Linda McInnes 531
24 New Drug May Boost Hepatitis C Treatment Linda McInnes 378
25 Hepatitis C treatment breakthrough Linda McInnes 686
26 IL28B gene predicts treatment outcome for liver transplantation patients Linda McInnes 791
27 Collaboration of Two HCV Pharmaceuticals Linda McInnes 374
28 Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV Linda McInnes 320
29 Two Supplements May Strengthen Hep C Antiviral Treatment Linda McInnes 343
30 Boceprevir Officially Fast-Tracked Linda McInnes 1168
31 Final Results of Clinical Trial on Boceprevir Linda McInnes 590
32 Combination of Two Oral Drugs Shows Promise for HCV in Small Study Linda McInnes 338
33 SVR Not Required to Benefit from Hepatitis C Treatment Linda McInnes 565
34 Hep C may benefit from genetic fingerprinting, research says Linda McInnes 358
35 New Stem Cell Technology Could Benefit Hepatitis C Linda McInnes 629
36 TV Show Delivers Hope for Hepatitis C Linda McInnes 336
37 65% of People Whose Prior Treatment for Hepatitis C Was Unsuccessful Achieved SVR (Viral Cure) with Telaprevir-Based Therapy in Phase 3 REALIZE Study Linda McInnes 1061
38 Advances in HCV Diagnostics: OraQuick® HCV Rapid Antibody Test; The Bisosensor Linda McInnes 413
39 Extended Treatment of HCV Type 1 Beneficial in Slow Responders Linda McInnes 277
40 Imminent Launch of Small-molecule Antiviral Drugs Poised to Enhance Treatment Success Rates for Hepatitis C Patients, Finds Frost & Sullivan Linda McInnes 358
41 Hepatitis C Treatments in Current Clinical Development Linda McInnes 418
42 Sustained Response to Antiviral Therapy Prevents Esophageal Varices in Hepatitis C Patients with Cirrhosis Linda McInnes 639
43 Groundbreaking Drug-Free Treatment for Hepatitis C Linda McInnes 596
44 Hepatitis C treatment may depend on genetic variant Linda McInnes 394
45 New use for old drugs in treating hepatitis C Linda McInnes 591
46 ZymoGenetics Initiates PEG-Interferon lambda Phase 2b Clinical Trial in Hepatitis C in Collaboration with Bristol-Myers Squibb Linda McInnes 441
47 Physicians May Use Risk-Based Screening Strategy to Identify Hepatitis C Virus Infection Linda McInnes 243
48 75% of Treatment-Naïve Patients with Chronic Hepatitis C Achieve SVR (Viral Cure) with Telaprevir-Based Treatment in Phase 3 Trial Linda McInnes 578
49 Treatment for Hepatitis C with Antiviral Supplement Gene-Eden, a New Opportunity? Linda McInnes 621
50 Romark Releases Stealth C-3 Phase 2 Results Linda McInnes 309
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  4 
  •  5 
  •  6 
  •  7 
  •  8 
  •  Next 
  •  End 
  • »
Page 1 of 8